High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with

Martijn P D Haring1, Fabian Peeks2, Maaike H Oosterveer3

  • 1Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Insights

High childhood triglycerides increase hepatocellular adenoma (HCA) risk in glycogen storage disease type Ia (GSDIa). This finding is independent of G6PC1 genotype and sex, highlighting TG as a key factor for HCA development.

Area of Science:

  • Metabolic disorders
  • Genetics
  • Hepatology

Background:

  • Glycogen storage disease type Ia (GSDIa) is an inherited metabolic disorder linked to hepatocellular adenoma (HCA) formation.
  • Risk factors for HCA in GSDIa patients are not well-established.
  • This study investigates GSDIa, G6PC1 genotype, sex, and triglyceride levels as potential HCA risk factors.

Purpose of the Study:

  • To identify risk factors for hepatocellular adenoma (HCA) development in patients with Glycogen storage disease type Ia (GSDIa).
  • To investigate the association of GSDIa with sex, G6PC1 genotype, and serum triglyceride (TG) levels in relation to HCA occurrence.

Main Methods:

  • Observational study including genetically confirmed GSDIa patients aged 12 years and older.
  • Patients were categorized by sex, number of predicted severe G6PC1 variants (PSV), and childhood median triglyceride (TG) levels (< or > 5.65 mmol/L).
  • Statistical analyses included log-rank tests and Cox regression to assess HCA development risk.

Main Results:

  • Hepatocellular adenoma (HCA) developed in 26 of 53 GSDIa patients by a median age of 21 years.
  • Females had a higher incidence of HCA by age 25 (48% vs. 30%).
  • High childhood triglycerides (>5.65 mmol/L) were an independent risk factor for HCA development (HR 6.0), associated with earlier onset (18 vs. 33 years).

Conclusions:

  • High childhood serum triglyceride concentrations are associated with an increased risk and earlier onset of hepatocellular adenoma (HCA) in GSDIa patients.
  • This association is independent of G6PC1 genotype and sex-specific hypertriglyceridemia.
  • Serum triglyceride levels during childhood are a significant predictor of HCA development in GSDIa.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
290
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
236
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
607
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.8K